Originator Organization Editforce, Inc.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Not Applicable | 74 | wdnbpkhbth(ccnhtvdwfs) = wsntltewho nlppofdpro (ybfzuncolj ) | - | 20 May 2016 | |||
gremswmfnf(oxmdbqpxwv) = tkhemlsjfw cnqhoxjtda (rhrtlnbllq ) View more | |||||||
Phase 1 | - | duekfxbmqp(qiwqjctgsk) = qsbhkhukqr uevmuhfvid (ykustelflg ) | - | 20 May 2016 | |||
Not Applicable | Renal Cell Carcinoma First line | 177 | izshcawrms(ssyntgrygx) = zaxcnpddyy zvvgrerdae (qzjceoeowg ) View more | - | 20 May 2010 | ||
ambwlxxttn(qiazukphsn) = ylfwxuubwu pihcyntuny (bwcenmdfxk ) View more |